Cargando…
Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial
INTRODUCTION: Established thresholds for patient-reported outcomes (PROs) provide clinically relevant responder data from trials. Lorecivivint (LOR) is an intra-articular (IA) therapy in development for knee osteoarthritis (OA). A post hoc analysis from a phase 2b trial (NCT03122860) determined prop...
Autores principales: | Tambiah, Jeyanesh R. S., Kennedy, Sarah, Swearingen, Christopher J., Simsek, Ismail, Yazici, Yusuf, Farr, Jack, Conaghan, Philip G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217418/ https://www.ncbi.nlm.nih.gov/pubmed/34101138 http://dx.doi.org/10.1007/s40744-021-00316-w |
Ejemplares similares
-
Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study
por: Fineman, Mark S., et al.
Publicado: (2023) -
Lorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial
por: Yazici, Yusuf, et al.
Publicado: (2020) -
Effect of lorecivivint on osteoarthritis: A systematic review and meta-analysis
por: Kou, Haiyang, et al.
Publicado: (2023) -
Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
por: Bedenbaugh, Angela V, et al.
Publicado: (2021) -
Use of intra-articular hyaluronic acid in knee osteoarthritis or osteoarthritis
por: Anhesini, Mauricio, et al.
Publicado: (2023)